Nachrichten zur Edwards Lifesciences Corp. Aktie

Edwards Lifesciences Aktie: Überraschend vielversprechend

Die Edwards Lifesciences Aktie verzeichnete am 2. November 2024 einen erneuten Anstieg und setzte damit ihren positiven Trend der letzten…

EDWARDS LIFESCIENCES has been Sued for Securities Fraud after Stock Plummets 31%; Contact the Firm before December 13 Class Action Deadline (NYSE:EW)

Edwards Lifesciences Corporation investors that lost money on their investment are encouraged to contact BFA Law before December 13, 2024…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against TD, Edwards, and UPS and Encourages Investors to Contact the Firm

NEW YORK, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

Edwards Lifesciences Q3: Divesting Critical Care And Focusing On Structural Hearts

…

EW INVESTOR ALERT: Edelson Lechtzin LLP Urges Edwards Lifesciences Corporation (NYSE: EW) Shareholders to Seek Legal Counsel About the Pending Securities Fraud Class Action

Edelson Lechtzin LLP announces the filing of a securities fraud class action on behalf of all purchasers of Edwards Lifesciences…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Elanco, Edwards, and UPS and Encourages Investors to Contact the Firm

NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

EW INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SAN DIEGO, Oct. 19, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or…

EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Investors With Large Losses in Edwards Lifesciences Corporation Should Contact Bernstein Liebhard LLP To Discuss Their Rights

EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Investors With Large Losses in Edwards Lifesciences Should Contact Bernstein Liebhard LLP…

EDWARDS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corp and Encourages Investors to Contact the Firm

NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights…

EW INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead the Edwards Lifesciences Class Action Lawsuit

SAN DIEGO, Oct. 14, 2024 (GLOBE NEWSWIRE) --  Robbins Geller Rudman & Dowd LLP announces that purchasers or…

Is it the Right Time to Hold EW Stock in Your Portfolio Now?

Edward Lifesciences Critical Care divestiture bodes well for its Structural Heart portfolio. Yet, macroeconomic issues raise worry for its operations.…

Edwards Lifesciences Aktie: Leichter Rückgang trotz solider Aussichten

Die Edwards Lifesciences Aktie verzeichnete am 21. September 2024 einen leichten Rückgang von 0,57% auf 66,84 USD. Trotz dieses kleinen…

Edwards Lifesciences: Solvable Problems Offer Excellent Opportunities

…

BD Stock Falls After Acquisition of Edwards Critical Care Group

BDX expands its smart care portfolio by acquiring Edwards Lifesciences Critical Care group, now BD Advanced Patient Monitoring, strengthening AI-driven…

Should You Hold Edward Lifesciences (EW) in Your Portfolio Now?

Edward Lifesciences (EW) promising TAVR business and the Critical Care divestment move bode well in the long term.…

Edwards Lifesciences (EW) Q2 Earnings Meet Mark, Margins Crash

Edwards Lifesciences (EW) reports strong contributions from the TMTT product group in the second quarter of 2024.…

After-hours movers: Chipotle Mexican Grill, Ford, IBM, Edwards Lifesciences, and more By Investing.com

After-hours movers: Chipotle Mexican Grill, Ford, IBM, Edwards Lifesciences, and more…

Edwards Lifesciences Crumbles On Slashed TAVR Outlook

The company now expects full-year sales in its TAVR division to climb 5% to 7%.…

Edwards Lifesciences (EW) Buys Innovalve to Boost TMVR Solutions

Edwards Lifesciences (EW) exercises the option to acquire Innovalve Bio-Medical Ltd., strengthening its TMVR technology portfolio and addressing unmet…

Is a Beat Likely for Edwards Lifesciences (EW) in Q2 Earnings?

Edwards Lifesciences (EW) TMTT segments PASCAL platform is likely to have maintained strong growth momentum in the second quarter…

Edwards Lifesciences: Focus On The Heart

…

Aktienmarkt: Edwards Lifesciences-Aktie tritt auf der Stelle (85,6517 €)

Wenig Kursbewegung aktuell bei dem Anteilsschein von Edwards Lifesciences . Das Papier kostete zuletzt 91,47 US-Dollar. Die Wertschätzung der Investoren…

Edwards Lifesciences Corp Looks Bullish (Technical Analysis)

…

Edwards Lifesciences Stock Jumps On Surprise $4.2 Billion Deal

Edwards Lifesciences stock rallied Monday on medtech giant Becton Dickinsons plan to buy a key division for $4.2 billion.…

Edwards Lifesciences exec sells shares worth over $73k By Investing.com

Edwards Lifesciences exec sells shares worth over $73k…

Edwards Lifesciences: EPS Acceleration, Shares Poised To Rally (Rating Upgrade)

…

The Zacks Analyst Blog Highlights Salesforce, BP, The Southern, PayPal and Edwards Lifesciences

Salesforce, BP, The Southern, PayPal and Edwards Lifesciences are included in this Analyst Blog.…

Earnings call: Edwards Lifesciences sees robust Q1 growth, raises guidance By Investing.com

Earnings call: Edwards Lifesciences sees robust Q1 growth, raises guidance…

Edwards Lifesciences stock maintains $100 target and Buy rating By Investing.com

Edwards Lifesciences stock maintains $100 target and Buy rating…

Global Cardiovascular Surgical Devices Market Expected to Surge to US$ 2.77 Billion by 2032 - Technological Innovations and Approvals Boosting the Market

Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "Cardiovascular Surgical Devices Market, Size, Share, Global Forecast 2024-2032, Industry…

Edwards Lifesciences exec sells over $1.1m in company stock By Investing.com

Edwards Lifesciences exec sells over $1.1m in company stock…

Edwards Lifesciences executive sells over $2.7 million in stock By Investing.com

Edwards Lifesciences executive sells over $2.7 million in stock…

Edwards Lifesciences Corporations (NYSE:EW) Stock Is Going Strong: Is the Market Following Fundamentals?

Edwards Lifesciences (NYSE:EW) has had a great run on the share market with its stock up by a significant 23%…

Edwards Lifesciences shares target raised by Oppenheimer on valve therapy outlook By Investing.com

Edwards Lifesciences shares target raised by Oppenheimer on valve therapy outlook…

Edwards Lifesciences (EW) Hits 52-Week High: Whats Driving It?

Edwards Lifesciences (EW) outperforms the industry, owing to a robust 2023 fourth-quarter performance, as well as the strong potential in…

Edwards Lifesciences Corp. stock outperforms competitors on strong trading day

Shares of Edwards Lifesciences Corp. rose 2.22% to $92.93 Wednesday, on what proved to be an all-around mixed trading session…

Edwards Lifesciences (EW) SAPIEN TAVR Study Outcome Favorable

Edwards Lifesciences (EW) recent study provides insights into the actual performance of small Edwards valves and reaffirms the excellent outcomes…

Edwards Lifesciences stock upgraded to buy, PT lifted to $105 By Investing.com

Edwards Lifesciences stock upgraded to buy, PT lifted to $105…

Edwards Lifesciences (EW) Wins FDA Nod for the EVOQUE System

Edwards Lifesciences (EW) EVOQUE valve replacement system becomes the first transcatheter therapy to earn FDA approval for a tricuspid valve.…

FDA approves Edwards Lifesciences EVOQUE valve system By Investing.com

FDA approves Edwards Lifesciences EVOQUE valve system…

Whats in Store for Edwards Lifesciences (EW) in Q4 Earnings?

Edwards Lifesciences (EW) Q4 results are likely to reflect continued demand for its state-of-the-art HemoSphere monitoring platform and Smart Recovery…

Edwards Lifesciences: Undervalued With A Substantial Upside Potential

…

Edwards Lifesciences (EW) Forwards Growth Strategy and Outlook

Edwards Lifesciences (EW) TAVR remains strong, driven by greater awareness, patient activation and advances in new technologies such as RESILIA.…

: Edwards Lifesciences to spin off Critical Care unit, sets $1B stock buyback

Edwards Lifesciences Corp.’s stock EW rose 1.9% in premarket trading Thursday after it said it plans to form an…

Edwards Lifesciences stock dips, ending four-day rally as market declines By Investing.com

Edwards Lifesciences stock dips, ending four-day rally as market declines…

Edwards Lifesciences cut by Wolfe Research on risk of US TAVR disappointing By Investing.com

Edwards Lifesciences cut by Wolfe Research on risk of US TAVR disappointing…

Edwards Lifesciences Q3: Clinical Trial Updates Impress

…

Edwards Lifesciences: Sector Derating A Bigger Threat Than Competition Or Slowing Markets

…

Edwards Lifesciences tumbles as guidance misses expectations By Investing.com

Edwards Lifesciences tumbles as guidance misses expectations…

Edwards Lifesciences (EW) Q3 Earnings Match Mark, Margins Dip

Edwards Lifesciences (EW) TMTT performance benefits from the accelerated adoption of the differentiated PASCAL precision platform in the third quarter.…